Global markets have risen over hopes of a COVID-19 vaccine from Oxford University.
Researchers said they were on schedule to have the vaccine ready for mass production as soon as September.
They said the drug triggered a sharp rise in antibodies and immune system T cells which help to clear infections from the body, while the antibodies were able to kill the virus in the lab.
Further clinical trials are underway in the UK, South Africa and Brazil on the drug as it did not indicate whether it would protect people against the virus.
Markets in Europe, Japan, America and China all went up overnight by 0.7 per cent.
Image: AP
